PDE3 inhibitor

PDE3 inhibitor is a type of drug that inhibits the action of phosphodiesterase 3 (PDE3), an enzyme found in the heart and blood vessels. PDE3 inhibitors are used in the treatment of heart failure and other cardiovascular conditions.

Mechanism of action

PDE3 inhibitors work by blocking the action of PDE3, an enzyme that breaks down cyclic adenosine monophosphate (cAMP) in the heart and blood vessels. By inhibiting PDE3, these drugs increase the levels of cAMP, which in turn enhances the contractility of the heart muscle and causes vasodilation. This results in improved heart function and increased blood flow.

Uses

PDE3 inhibitors are used in the treatment of heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. They are also used to treat certain types of arrhythmia, or irregular heartbeat.

In addition, PDE3 inhibitors are used in the management of pulmonary hypertension, a condition characterized by high blood pressure in the arteries of the lungs. By causing vasodilation, these drugs can help to reduce the pressure in these arteries and improve symptoms.

Examples

Examples of PDE3 inhibitors include milrinone, cilostazol, and enoximone. Milrinone and enoximone are typically used in the treatment of heart failure, while cilostazol is used to treat intermittent claudication, a condition characterized by pain in the legs due to inadequate blood flow.

Side effects

Like all drugs, PDE3 inhibitors can cause side effects. These may include nausea, vomiting, headache, and arrhythmia. In rare cases, PDE3 inhibitors can cause severe cardiovascular side effects, such as cardiac arrest or stroke.

See also

• Phosphodiesterase inhibitor
• Heart failure
• Pulmonary hypertension

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

PDE3_inhibitor

• 

  Milrinone chemical structure

• 

  CI-930 HPI pattern

• 

  Theophylline chemical structure

• 

  Meribendan skeletal formula

• 

  CI-930 skeletal formula